Sulfonylurea active pharmaceutical ingredient employed in oral hypoglycemic agents. Generic pharmaceutical companies source it for tablet manufacturing to treat type 2 diabetes, particularly in cardiovascular disease prevention protocols. Supplied to formulation facilities for integration into sustained-release dosage forms.